from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0873/fadE10

LFCtreatmentdescriptionclass of inhibitor

2.014

Amikacinug/mL Amikacintranslation

2.140

Cap5-10ug/mL Capreomycintranslation

1.299

Rox10-50 ug/mL Roxithromycintranslation

-0.110

SM2-5 ug/mL Streptomycintranslation

2.668

Tet5-10 ug/mL Tetracyclinetranslation

-0.522

Rif0.2-5ug/mL Rifampicintranscription

-0.302

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.940

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.591

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.940

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.734

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.185

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.119

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.635

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.942

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.175

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.587

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.533

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.726

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.535

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.568

KCN5-20 ug/mL Potassium cyaniderespiration

0.306

NaN30.2-2 mM Sodium aziderespiration

0.874

Nigericin50 uM Nigericinrespiration

0.308

TRC10-150 ug/mL Triclosanrespiration

1.214

TRZ10-25 ug/mL Thioridazinerespiration

0.229

Valinomycin0.5-10 uM Valinomycinrespiration

-0.343

ZnSO42 mM ZnSO4respiration

1.847

menadione6-10 ug/mL Menadionerespiration

-0.326

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.278

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.026

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.149

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.066

NRP_1Non-replicating persistence stage 1dosRassociated

-0.322

Amp0.2mg/mL AmpicillincellWall

0.012

Cephalexin20-100 ug/mL CephalexincellWall

-0.057

Cerulenin0.32-5 ug/mL CerulenincellWall

0.590

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.255

EMB10-20 ug/mL EthambutolcellWall

-0.039

Eta12-40 ug/mL EthionamidecellWall

0.081

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.208

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.044

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.001

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.506

BZA0.12 mg/mL BenzamidearomaticAmides

-0.534

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.559

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.630

H2O24 mM hydrogen peroxideDNAdamaging

0.193

Levo10 ug/mL LevofloxacinDNAdamaging

0.075

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.867

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.249

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.534

UVUV-irradiationDNAdamaging

0.149

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.133

Antimycin12.5-50 ug/mL Antimycin A?

0.171

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.306

PA_110-50 ug/mL Antitubercular compound PA-1?

0.057

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.321

PA8240.2-2 ug/mL PA-824?

-1.400

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.775

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.226

Verapamil50 uM Verapamil?

0.591

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.722

methoxatin10-20 ug/mL Methoxatin?